(Q48217249)

9 February 2018

title

Multiple sclerosis: a study of chemokine receptors and regulatory T cells in relation to MRI variables (English)

1 reference

9 February 2018

0 references

7

1 reference

9 February 2018

author name string

P Putheti

1

1 reference

9 February 2018

M Morris

2

1 reference

9 February 2018

L Stawiarz

3

1 reference

9 February 2018

N Teleshova

4

1 reference

9 February 2018

P Kivisäkk

5

1 reference

9 February 2018

M Pashenkov

6

1 reference

9 February 2018

M K Wiberg

8

1 reference

9 February 2018

L Bronge

9

1 reference

9 February 2018

Y-M Huang

10

1 reference

9 February 2018

M Söderström

11

1 reference

9 February 2018

J Hillert

12

1 reference

9 February 2018

H Link

13

1 reference

9 February 2018

publication date

1 September 2003

1 reference

9 February 2018

European Journal of Neurology

published in

1 reference

9 February 2018

volume

10

1 reference

9 February 2018

issue

5

1 reference

9 February 2018

page(s)

529-535

1 reference

9 February 2018

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Longitudinal study of antimyelin T-cell reactivity in relapsing-remitting multiple sclerosis: association with clinical and MRI activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Serum cytokine levels do not correlate with disease activity and severity assessed by brain MRI in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Chemokines: immunology's high impact factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Increased production of tumor necrosis factor alpha, and not of interferon gamma, preceding disease activity in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC- cells and CD4(+)CD8(-) thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Certified professionals: CD4(+)CD25(+) suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Immunological disturbances in the central nervous system linked to MRI findings in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Aberrant T cell migration toward RANTES and MIP-1 alpha in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

CD4+CD25high regulatory cells in human peripheral blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Cytokine gene expression in cells derived from CSF of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Expression of chemokine receptor CXCR3 on cerebrospinal fluid T-cells is related to active MRI lesion appearance in patients with relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Expression pattern of activation and adhesion molecules on peripheral blood CD4+ T-lymphocytes in relapsing-remitting multiple sclerosis patients: a serial analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

Relationship between serum levels of IL-10, MRI activity and interferon beta-1a therapy in patients with relapsing remitting MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1468-1331.2003.00638.X

10.1046/J.1468-1331.2003.00638.X

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018